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Abstract
Myocardial infarction (MI), characterized by ischemia-induced cardiomyocyte apoptosis, is the leading cause of
mortality worldwide. NR4A2, a member of the NR4A orphan nucleus receptor family, is upregulated in mouse hearts
with MI injury. Furthermore, NR4A2 knockdown aggravates heart injury as evidenced by enlarged hearts and increased
apoptosis. To elucidate the underlying mechanisms of NR4A2-regulated apoptosis, we used H9c2 cardiomyocytes
deprived of serum and neonatal rat cardiomyocytes (NRCMs) exposed to hypoxia to mimic ischemic conditions
in vivo. As NR4A2 knockdown aggravates cardiomyocyte apoptosis, while NR4A2 overexpression ameliorates it, NR4A2
upregulation was considered an adaptive response to ischemia-induced cardiomyocyte apoptosis. By detecting
changes in LC3 and using autophagy detection tools including Baﬁlomycin A1, 3MA and rapamycin, we found that
NR4A2 knockdown promoted apoptosis through blocking autophagic ﬂux. This apoptotic response was phenocopied
by downregulation of NR4A2 after autophagic ﬂux was impaired by Baﬁlomycin A1. Further study showed that NR4A2
binds to p53 directly and decreases its levels when it inhibits apoptosis; thus, p53/Bax is the downstream effector of
NR4A2-mediated apoptosis, as previously reported. Changes in p53/Bax that were regulated by NR4A2 were also
detected in injured hearts with NR4A2 knockdown. In addition, miR-212-3p is the upstream regulator of NR4A2, and it
could downregulate the expression of NR4A2, as well as p53/Bax. The mechanism underlying the role of NR4A2 in
apoptosis and autophagy was elucidated, and NR4A2 may be a therapeutic drug target for heart failure.

Introduction
Myocardial infarction (MI), characterized by ischemiainduced cardiomyocyte death, is one of the leading causes
of death worldwide1. Cardiomyocytes are terminally differentiated cells, and cardiomyocyte death irreversibly
damages the structure and function of the heart and leads
to myocardial ﬁbrosis, heart failure and other adverse
cardiac events2,3. There are two kinds of cell death in MI
injury: necrosis and apoptosis4. As apoptosis can be
regulated by signaling pathways, a better understanding of
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the mechanisms modulating cardiomyocyte apoptosis is
critical for identifying effective treatments for patients
with ischemic heart diseases.
Autophagy, a well-conserved intracellular lysosomal
degradation process, is particularly important to the
homeostasis of terminally differentiated cells5. It is
reported that autophagy occurs in ischemic cardiomyocytes to provide essential energy for cell survival by
clearing disordered organelles or aging proteins4. A
moderate amount of autophagy is beneﬁcial to cell survival, while excessive autophagy may lead to cell death6,7.
Given the complex crosstalk between apoptosis and
autophagy, the key factors involved in apoptosis and
autophagy still need more research for the development of
potent drug targets8,9.
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Nuclear receptor subfamily 4, group A, member 2
(NR4A2), also known as Nurr1, is a member of the NR4A
orphan nuclear receptor family with NR4A1 and
NR4A310. The NR4A family belongs to the immediate
early response transcription factors, which can quickly
respond to ischemic stroke11. NR4A2 participates in
stress-induced apoptosis of various cancer cells with different functions, indicating that it has a cell-speciﬁc role
in apoptosis12. The role of NR4A2 in cardiomyocyte
apoptosis has remained elusive. Furthermore, a recent
report showed that NR4A2 increased in association with
cell autophagy in neuronal survival13, but its association
with autophagy remains unknown. Here, we aimed to
clarify the function of NR4A2 in cardiomyocyte apoptosis
and autophagy in order to determine whether it is a
potential therapeutic target for ischemic heart diseases.
Given that NR4A2 may play an important role in
ischemic cardiomyocytes, understanding its regulation is
important. MicroRNAs (miRNAs) are a group of noncoding single-stranded RNA molecules that can bind to
target messenger RNAs (mRNAs), resulting in a decrease
in their translation14. In this study, the preliminary
miRNA microarray results associated with predictive
analysis by TargetScan suggested that miR-212-3p was
the potential miRNA targeting NR4A2. MiR-212-3p
possesses highly conserved sequences among vertebrates, and its expression is high in both the brain and
heart, suggesting that it has an important role in the heart.
Most research on miR-212-3p has focused on its roles in
the development of tumors and neurons, but its function
in heart has been less reported15,16. It has been reported
that miR-212-3p promoted angiogenesis to attenuate
ischemic heart disease by inhibiting the expression of
Rasa1/Spred1, thus upregulating Ras/mitogen-activated
protein kinase17. Currently, the function of miR-212-3p in
ischemia-induced cardiomyocyte apoptosis is unknown.
Here, we studied the role of NR4A2 in ischemiainduced cardiomyocyte apoptosis and autophagy and
reported a miR-212-3p/NR4A2/p53/Bax pathway in
autophagy-dependent apoptosis in ischemia-stimulated
cardiomyocytes.

Results
NR4A2 knockdown aggravated MI-induced heart injury

Seven days of permanent coronary ligation caused
severe cardiac dysfunction, as we previously reported
(Fig. 1a)18. NR4A2 expression increased in mouse hearts
with MI injury as detected by real-time quantitative PCR
(qPCR; Fig. 1b). We injected the interfering lentivirus of
NR4A2 (lv3-siNR4A2) or negative control into hearts
with MI. The qPCR results veriﬁed the knockdown effect
of lv3-siNR4A2 in vivo (Fig. 1c). After 7 days of permanent coronary ligation, compared with control mice, mice
injected with lv3-siNR4A2 exhibited enlarged hearts
Ofﬁcial journal of the Cell Death Differentiation Association
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(Fig. 1d), and lv3-siNR4A2 increased the expression of the
apoptosis markers poly(ADP-ribose) polymerase (PARP)
and caspase3, as well as the autophagy marker LC3
(Fig. 1e, f), suggesting that NR4A2 knockdown aggravates
MI-induced heart injury.
Upregulated expression of NR4A2 in ischemic
cardiomyocytes

H9c2 cardiomyocytes deprived of serum were used to
mimic ischemic conditions19. To investigate the possible
involvement of NR4A2 in cardiomyocyte apoptosis, we
analyzed the changes in NR4A2 in H9c2 cardiomyocytes
exposed to ischemia. When ischemia lasted for more than
4 h, NR4A2 increased as shown by qPCR, western blot
and immunoﬂuorescence (Fig. 2a–c).
NR4A2 protected cardiomyocytes from apoptosis

To evaluate the function of NR4A2 in ischemia-induced
cardiomyocyte apoptosis, we used NR4A2 small interfering RNA (siRNA) to knockdown its expression. The qPCR
and western blot analyses were used to verify the
knockdown effect of NR4A2 siRNA in cardiomyocytes
(Fig. 3a, b). Then, H9c2 cardiomyocytes and neonatal rat
cardiomyocytes (NRCMs) exposed to ischemia were both
used to detect the effects of NR4A2 knockdown on
ischemia-induced cardiomyocyte apoptosis. The levels of
cleaved PARP and caspase3 in H9c2 cardiomyocytes and
NRCMs with NR4A2 knockdown were both higher than
those in controls (Fig. 3c), and terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) staining
showed more Fluorescein isothiocyanate (FITC)-positive
cells in the NR4A2 knockdown group than in the control
group (Fig. 3d), suggesting that NR4A2 knockdown promoted cardiomyocyte apoptosis. In addition, we used
overexpression to verify the functions of NR4A2. As
shown, compared with NR4A2 knockdown, NR4A2
overexpression had the opposite effect (Fig. 3e); thus,
NR4A2 protects cells from ischemia-induced cardiomyocyte apoptosis.
NR4A2 enhanced autophagic ﬂux in cardiomyocytes

Autophagy occurs in hearts with MI injury, and it is
now considered a therapeutic target for ischemic heart
disease20. Recent studies reported that NR4A2 might be
involved in autophagy21. In this study, NR4A2 knockdown
increased ischemia-induced LC3-II upregulation in H9c2
cardiomyocytes and NRCMs and LC3 patches in H9c2
cells (Fig. 4a, b), suggesting that NR4A2 knockdown
changed cardiomyocyte autophagy. Decreases in LC3-II
levels after NR4A2 overexpression further conﬁrmed that
NR4A2 regulates autophagy (Fig. 4c).
To further conﬁrm the change in LC3-II caused by
autophagic initiation promotion or autophagic ﬂux
blocking, we used the autophagy inhibitors Baﬁlomycin
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Fig. 1 NR4A2 knockdown aggravated MI-induced heart injury. a The heart function was analyzed by echocardiography and the changes of EF
and FS were revealed. b NR4A2 expression in sham and MI mice was detected by qPCR. Mice with MI injury were injected with lv3-siNR4A2 or
controls for 7 days, and then the hearts were harvested. c The knockdown effect of lv3-siNR4A2 was detected by qPCR. d Gross morphology of the
heart. e Caspase3 was detected by immunoﬂuorescence. f PARP and LC3 levels were observed by western blotting. Data are expressed as the mean
+ S.D. **P < 0.01; n = 6

A1 (Baf A1), NH4Cl and 3-methyladenine (3MA). Western blot results showed that when autophagic ﬂux
blockers Baf A1 or NH4Cl were added, there was signiﬁcant augmentation of LC3-II in negative controls, and
NR4A2 knockdown could not increase LC3-II further
(Fig. 4d). In addition, 3MA could not decrease LC3-II
levels in the NR4A2 knockdown group (Fig. 4e), suggesting that NR4A2 knockdown blocked autophagic ﬂux
but did not affect autophagy initiation.
Ofﬁcial journal of the Cell Death Differentiation Association

NR4A2 knockdown promoted cardiomyocyte apoptosis by
inhibiting autophagic ﬂux

To elucidate the function of NR4A2-mediated autophagy on myocardial apoptosis, we used autophagy tools
including Baf A1, 3MA and rapamycin. After the autophagy inhibitor 3MA was added, the levels of cleaved PARP
and caspase3 induced by NR4A2 knockdown further
increased (Fig. 5a), while the autophagy promoter rapamycin signiﬁcantly decreased the levels of cleaved PARP
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Fig. 2 Expression of NR4A2 increased in cardiomyocytes exposed to ischemic conditions. a, b H9c2 cells were deprived of serum for 4 h, 8 h
and 12 h, and the expression of NR4A2 was analyzed by a qPCR and b western blot. c H9c2 cells were cultured exposed to ischemic conditions
(deprived of serum for 12 h), and the expression of NR4A2 was observed by immunoﬂuorescence. Nor normal. Data are expressed as the mean + S.D.
*P < 0.05; **P < 0.01; n = 3

and caspase3 (Fig. 5b), suggesting that NR4A2 knockdown promoted apoptosis via autophagy inhibition.
Because impeding the autophagic ﬂux was the key to
inhibiting autophagy, the autophagic ﬂux blocker Baf A1
was added to cells with NR4A2 knockdown. As a result,
the levels of cleaved PARP and caspase3 were not changed
in Baf A1-treated NR4A2 knockdown cells compared with
the levels in cells with NR4A2 knockdown alone, suggesting that the two groups used the same mechanism to
induce apoptosis; that is, NR4A2 knockdown promoted
apoptosis by blocking autophagic ﬂux (Fig. 5c).
NR4A2 inhibited apoptosis through interaction with p53

P53 might be the downstream factor of NR4A2 that
inhibits Bax expression and induces apoptosis22. We used
NR4A2 siRNA and an overexpression plasmid to detect
the relationship between NR4A2 and p53. Western blot
results showed that NR4A2 knockdown increased p53
and Bax levels, while NR4A2 overexpression decreased
these levels (Fig. 6a, b). Co-immunoprecipitation (Co-IP)
results revealed that p53 could bind to NR4A2 (Fig. 6d).
We also used immunoﬂuorescence to verify the colocalization of NR4A2 and p53 (Fig. 6c). The data revealed
that p53 was the direct downstream target of NR4A2. To
Ofﬁcial journal of the Cell Death Differentiation Association

ascertain whether NR4A2 could regulate p53 and Bax
in vivo, p53 and Bax levels in MI mouse hearts with
NR4A2 knockdown were observed by western blot
(Fig. 6e), and the same result was observed as in vitro.
NR4A2 was the target of miR-212-3p

NR4A2 plays an important role in autophagy and
apoptosis, but the mechanism regulating NR4A2 is still
unknown. Bioinformatics tools (http://www.targetscan.
org) predicted that miR-212-3p was a putative miRNA
targeting NR4A2 based on target sequences at the NR4A2
3′ untranslated region (UTR). First, miR-212-3p expression and function was detected in cardiomyocytes
exposed to ischemia. The qPCR showed that miR-212-3p
decreased in ischemic conditions (Fig. 7a). An inhibitor of
miR-212-3p suppressed the cleavage of PARP and caspase3, and thus it inhibited cardiomyocyte apoptosis as
NR4A2 did, whereas a miR-212-3p mimic did not affect
the above-mentioned apoptosis markers, perhaps because
apoptosis was saturated (Fig. 7b).
To verify the regulation of NR4A2 by miR-212-3p, we
cloned the wild-type 3′UTR sequence of NR4A2 into a
luciferase reporter vector (Fig. 7c), and then we performed
a luciferase reporter assay to determine whether miR-212-
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Fig. 3 NR4A2 protects against ischemia-induced apoptosis in H9c2 cells and NRCMs. a, b H9c2 cells and NRCMs were transfected with
NR4A2 siRNA; the interference effect of siRNA was detected by a qPCR and b western blot. c After knockdown of NR4A2, the expression of PARP and
cleaved caspase3 in H9c2 cells and NRCMs exposed to ischemic conditions was observed by western blot. d Apoptosis-positive cells were detected
by TUNEL staining to show the ratio of apoptosis in H9c2 cells exposed to ischemia and treated with or without NR4A2 siRNA. e H9c2 cells were
transfected with pcDNA3.1-NR4A2 overexpression plasmid and then exposed to ischemic conditions (deprived of FBS for 12 h). Protein levels of
NR4A2, PARP and caspase3 were detected by western blot. Neg negative control, siN siNR4A2. Data are expressed as the mean + S.D. *P < 0.05; **P <
0.01; n = 3

3p could directly regulate the expression of NR4A2 in
H9c2 cardiomyocytes (Fig. 8). The results showed that the
luciferase activity linked to the wild-type 3′UTR of NR4A2
was repressed in H9c2 cells transfected with the miR-2123p mimic compared with that in control cells (Fig. 7c).
The qPCR and western blot results showed that the miR212-3p mimic inhibited NR4A2 –expression (Fig. 7d, e), as
well as the expression of p53 and Bax. All the data veriﬁed
Ofﬁcial journal of the Cell Death Differentiation Association

that miR-212-3p is the upstream regulator of NR4A2
(Fig. 7c–e).

Discussion
Ischemic heart disease is one of the leading causes of
mortality worldwide1. Cardiomyocyte apoptosis stimulated by a deﬁciency of oxygen and nutrients is the main
mechanism leading to heart failure23,24; thus,
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Fig. 4 NR4A2 promotes autophagic ﬂux of cardiomyocytes exposed to ischemic conditions. a H9c2 and NRCMs were transfected with
NR4A2 siRNA followed by ischemia treatment as methods. Changes in LC3 levels were analyzed by western blot. b H9c2 cells exposed to ischemia
were co-transfected with pEGFP-LC3 plasmid and NR4A2 siRNA, and then LC3 patches were revealed by immunoﬂuorescence. c H9c2 cells were
transfected with pcDNA3.1-NR4A2 overexpression plasmid for 48 h followed by serum deprivation for another 12 h, and then changes in LC3 levels
were analyzed by western blot. d, e H9c2 cells were transfected with NR4A2 siRNA for 36 h, followed by treatment with autophagy blockers (Baf A1,
NH4Cl and 3MA) in the ischemic condition for another 12 h. Then, LC3 levels were detected by western blotting. Baf A1 Baﬁlomycin A1, Rapa
rapamycin. Data are expressed as the mean + S.D. *P < 0.05; **P < 0.01; n = 3

understanding how to inhibit cardiomyocyte apoptosis is
important for designing effective heart failure therapies2,4.
In our study, NR4A2 was upregulated in murine cardiomyocytes exposed to ischemia. Further study revealed that
NR4A2 knockdown could aggravate, while overexpression
of NR4A2 could inhibit apoptosis stimulated by ischemia.
Our data suggested that induction of NR4A2 is an
adaptive response to resist cardiomyocyte apoptosis
caused by ischemia. Furthermore, NR4A2 knockdown in
Ofﬁcial journal of the Cell Death Differentiation Association

MI mice caused apoptosis and heart myocardial hypertrophy. It has been reported that NR4A2 plays important
roles in cancer, obesity, diabetes and neurological disease;
our results reported a new role for NR4A2 in ischemic
heart diseases25–28.
During ischemia, depleted serum triggered cardiomyocyte autophagic ﬂux to supply essential energy29,30. In this
case, autophagy is considered an adaptive reaction with
cardioprotective effects. We found that NR4A2 induced
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Fig. 5 NR4A2 knockdown increased the apoptosis of H9c2 through blocking autophagic ﬂux. H9c2 cells were transfected with NR4A2 siRNA
for 36 h followed by serum deprivation. a–c Baﬁlomycin A1, rapamycin and 3MA were added separately to H9c2 cells deprived of serum. After 12 h,
the PARP and cleaved caspase3 levels were detected by western blot. Data are expressed as the mean + S.D. *P < 0.05; **P < 0.01; n = 3

the above-mentioned protective autophagy. First, NR4A2
was also triggered by serum depletion, which is the same
as ischemia-induced autophagy. Second, NR4A2 regulated ischemia-induced autophagic ﬂux. In the current
study, cardiomyocyte apoptosis caused by ischemia was
attenuated by NR4A2-enhanced autophagy, suggesting
that NR4A2 might be used as a potential therapeutic
target for ischemic heart diseases.
The molecular mechanisms regulating NR4A2-induced
apoptosis and autophagy are unclear. According to a
previous report, NR4A2 interacts with p53 to inhibit the
expression of Bax to regulate apoptosis in lung cancer
cells31. Here, we found that p53/Bax also participated in
NR4A2-regulated cardiomyocyte apoptosis by binding to
p53 directly. Our data revealed that p53/Bax is the popular downstream factor of NR4A2.
As a member of orphan nuclear receptor family, NR4A2
expression is difﬁcult to regulate through its ligand.
MiRNAs can bind to the 3′UTR of target mRNAs to
inhibit the expression of speciﬁc genes. MiR-212-3p has
been shown to have important roles in regulating cardiac
hypertrophy32. It was reported that miR-132, one member
of the miR-132/212 cluster, is induced by H2O2 to target
Ofﬁcial journal of the Cell Death Differentiation Association

NR4A2 to aggravate apoptosis33, but whether NR4A2 is
the target of miR-212-3p in cardiomyocytes was
unknown. In our research, we found that miR-212-3p
expression decreased in ischemia, and its target NR4A2
increased, inhibiting the apoptosis of cardiomyocytes. Our
data suggested that miRNA regulates NR4A2 expression.
Furthermore, we reported a new role of miR-212-3p in
cardiomyocyte apoptosis and autophagy.
In conclusion, we elucidated the roles of NR4A2 in
apoptosis and autophagy in cardiomyocytes exposed to
ischemia, and we identiﬁed p53/Bax as its downstream
effectors. MiR-212-3p is the upstream regulator of NR4A2
expression in ischemic cardiomyocytes. Our data provide
a theoretical foundation for the future development of
therapeutics for ischemic heart diseases.

Materials and methods
Reagents

Dulbecco's modiﬁed Eagle's medium (DMEM) was
purchased from Gibco (Grand Island, NY, USA). NR4A2
and negative control siRNA were purchased from Ribbio
(Guangzhou, China). 3MA, Baﬁlomycin A1 and NH4Cl
were purchased from Sangon Biotech (Shanghai, China).

Liu et al. Cell Death Discovery (2018)4:27
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Fig. 6 NR4A2 decreased p53 levels and bound to p53. a, c H9c2 cells were transfected with NR4A2 siRNA for 36 h followed by serum deprivation
for another 12 h; then, p53 and Bax levels were analyzed by western blot (a). The possible colocalization of p53 and NR4A2 was detected by
immunoﬂuorescence (c). b, d H9c2 cells were transfected with pcDNA3.1-NR4A2 overexpression plasmid or vector plasmid followed by serum
deprivation; then, p53 and Bax levels were analyzed by western blot (b), and the interaction of p53 and NR4A2 was detected by co-IP assay (d). e
After MI for 7 days, the expression levels of p53 and Bax in the mouse heart with or without NR4A2 knockdown were detected by western blot. Data
are expressed as the mean + S.D. *P < 0.05; **P < 0.01; n = 3

Lipofectamine 2000 was purchased from Invitrogen
(Carlsbad, CA). NR4A2 antibody was purchased from
Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibodies for caspase3, PARP, LC3, p53 and Bax were from
Cell Signaling Technology (Beverly, MA, USA).
Animals

C57bl/6 mice (25 g) were purchased from the animal
center of Shandong University. The animal care and
experimental procedures involved in this study were
approved by the Institutional Animal Care and Use
Committee of Shandong University and agreed with the
American Physiological Society’s “Guiding Principles in
the Care and Use of Vertebrate Animals in Research and
Training”.
Ofﬁcial journal of the Cell Death Differentiation Association

MI model

Male C57bl/6 mice were divided into the following
groups: MI and MI plus interfering lentivirus against
NR4A2. Both groups had 6 surviving mice. MI was
induced by permanent ligation of the left anterior descending coronary artery for 7 days, and heart function was
detected by echocardiography as previously described18.
At the end of the experiment, the mice were killed, and
their hearts were collected for analysis.
Cell isolation, culture and treatment

NRCMs were obtained from the hearts of Wistar rats
born within 3 days, as previously reported34. NRCMs were
cultured in high glucose DMEM with 10% fetal bovine
serum (FBS) in humidiﬁed air with 5% CO2 at 37 °C. H9c2

Liu et al. Cell Death Discovery (2018)4:27
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Fig. 7 NR4A2 was the target of miR-212-3p in cardiomyocytes. a H9c2 cells were cultured in ischemic conditions (deprived of serum for 12 h).
Expression of miR-212-3p was analyzed by qPCR. b H9c2 cells were transfected with inhibitor or mimic of miR-212-3p followed by serum deprivation
for 12 h. Changes in PARP, caspase3 and LC3 were analyzed by western blot. c Website-predicted target of miR-212-3p and luciferase reporter
plasmid containing the native NR4A2 3’UTR was co-transfected with miR-212-3p mimic in HEK293 cells for 24 h followed by a dual-luciferase activity
assay. d H9c2 cells were transfected with miR-212-3p inhibitor in ischemic conditions, and NR4A2 levels were detected by qPCR. e H9c2 cells were
transfected with miR-212-3p inhibitor or mimic in ischemic conditions, and then, NR4A2, p53 and Bax were detected by western blot. Data are
expressed as the mean + S.D. *P < 0.05; **P < 0.01; n = 3

cells and HEK293 cells were cultured in DMEM with 10%
FBS in humidiﬁed air with 5% CO2 at 37 °C.
To mimic the ischemic situation, NRCMs were exposed
to DMEM deprived of glucose and FBS in a hypoxic
incubator (95% N2 and 5% CO2, 37 °C) for 3 h. H9c2 cells
were incubated in medium deprived of FBS for 12 h, as
previously described19.
Transfection of siRNA or overexpression plasmid

H9c2 or NRCMs were seeded in 60 mm cell culture
dishes and cultured in medium without antibiotics
Ofﬁcial journal of the Cell Death Differentiation Association

overnight. To knockdown the expression of NR4A2, cells
at 40% conﬂuence were transfected with NR4A2 siRNA
(20, 40, 80 nM) using Lipofectamine 2000 reagent
according to the manufacturer’s instructions. At 36 h after
transfection, NRCMs and H9c2 were incubated in
ischemic conditions for 12 h, as previously described.
To upregulate the expression of NR4A2 or LC3,
pcDNA3.1-NR4A2 (4 μg) or pEGFP-LC3 were transfected
into H9c2 cells by use of Lipofectamine 2000 reagent
(Invitrogen) for 48 h, followed by ischemic treatment for
another 12 h; then, the cells were used for analyses.

Liu et al. Cell Death Discovery (2018)4:27
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Fig. 8 The graphic image shows that ischemia inhibited the expression of miR-212-3p, thus increasing its target NR4A2 levels. NR4A2
protected cardiomyocytes from apoptosis through inhibiting p53/Bax and enhancing autophagic ﬂux

Real-time quantitative PCR

Total RNA was extracted from cardiomyocytes using
the TRIzol reagent (Invitrogen). The reverse transcription
step involved use of oligo (dT) primers, and then underwent qPCR (Roche, LightCycler 2.0 system, Basel, Switzerland) with the primer pair sequences for NR4A2,
forward,
5′-TGAGGGTCTGTGCGCTGTT-3′,
and
reverse, 5′-ACCTTTGCAGCCCTCACAAG-3′, and for
glyceraldehyde 3-phosphate dehydrogenase (GAPDH),
forward,
5′-GAGTATGTCGTGGAGTCTA-3′
and
reverse, 5′-CTAAGCAGTTGGTGGTG-3′. Relative gene
expression was normalized to GAPDH levels. The qPCR
reactions involved the use of a QuantiTect SYBR Green
PCR kit (Qiagen, Germany) and a LightCycler 2.0 system
(Roche). Reactions were carried out in a volume of 25 µl
with 12.5 µl of 2× SYBR Green PCR Master Mix. The fold
change was calculated by the 2-ΔΔCt method with MxPro
4.00 (Stratagene).
Western blot analysis

Total protein of H9c2 or NRCMs was collected with
RIPA lysis buffer on ice. Equal amounts of protein (30 μg)
underwent 12% sodium dodecyl sulfate–polyacrylamide
gel electrophoresis and were transferred to a polyvinylidene diﬂuoride membrane. After the membrane was
blocked with 5% non-fat milk for 1 h, it was incubated
with primary antibodies (1:1000) at 4 °C overnight and
incubated with horseradish peroxidase-conjugated secondary antibodies (1:5000) for 1 h at room temperature.
The immunoreactive bands were developed with an ECL
western blotting system. β-Actin was used as the loading
control. The relative levels of proteins were analyzed with
ImageJ software (National Institutes of Health, USA).
Immunoﬂuorescence staining

Treated cells were ﬁxed with 4% paraformaldehyde for
10 min at room temperature and incubated with NR4A2
antibodies (1:100) at 4 °C overnight; then, the cells were
washed with phosphate-buffered saline and incubated
Ofﬁcial journal of the Cell Death Differentiation Association

with secondary antibodies (1:200) for 1 h at 37 °C. Nuclei
were stained with 4',6-diamidino-2-phenylindole for 15
min at room temperature. Then, the ﬂuorescence was
observed by using a Zeiss LSM700 (Carl Zeiss Canada
Ltd). Fluorescence intensities were analyzed with ImageJ
software.
Protein Co-IP

H9c2 cells were transfected with an NR4A2 overexpression plasmid or with a negative control plasmid,
followed by ischemia treatment. At 60 h after transfection,
total protein was collected from cells by using IP lysis
buffer (Beyotime, Shanghai, China). After centrifugation
at 4 °C, the supernatant was isolated and incubated with
protein A/G agarose beads (Beyotime, Shanghai, China)
and green ﬂuorescent protein (GFP) antibody (Santa Cruz
Biotechnology, Santa Cruz, USA) at 4 °C overnight. The
beads were washed 3 times with IP lysis buffer and then
eluted with 4× SDS loading buffer. GFP and p53 were
detected by western blot assay with their protein-speciﬁc
antibodies (Cell Signaling Technology, Danfoss, USA).
Luciferase assay analysis

For the target assay, we constructed luciferase reporter
vectors containing the wild-type NR4A2 3′UTR. Then,
luciferase reporter plasmids were co-transfected with
control or miR-212-3p mimic into HEK293 cells with
Lipofectamine 2000 (Invitrogen). The transfected cells
were harvested 48 h after transfection, and the luciferase
activity was measured with the Dual-Luciferase Reporter
System (Promega)35.
Statistical analysis

Data are from at least three independent experiments
and expressed as the mean ± standard error. Statistical
analysis was performed with the paired Student's
t-test and analysis of variance with SPSS version 11.5.
Differences were considered statistically signiﬁcant at
P < 0.05.
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